Evidence map›Paper›PMID 33109661›Full record

ArticleBMJ open2020

Feasibility study for supporting medication adherence for adults with cystic fibrosis: mixed-methods process evaluation.

Daniel Hind, Sarah J Drabble, Madelynne A Arden, Laura Mandefield, Simon Waterhouse, Chin Maguire, Hannah Cantrill, Louisa Robinson, Daniel Beever, Alex Scott and 11 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Nebuliser systems for drug delivery in cystic fibrosis.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Daniel HindClincal Trials Research Unit, University of Sheffield, Sheffield, UK d.hind@sheffield.ac.uk.ORCID 0000-0002-6409-4793
Sarah J DrabbleSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
Madelynne A ArdenCentre for Behavioural Science and Applied Psychology, Sheffield Hallam University, Sheffield, UK.
Laura MandefieldDepartment of Health Sciences, University of York, York, UK.
Simon WaterhouseClincal Trials Research Unit, University of Sheffield, Sheffield, UK.
Chin MaguireClincal Trials Research Unit, University of Sheffield, Sheffield, UK.
Hannah CantrillClincal Trials Research Unit, University of Sheffield, Sheffield, UK.
Louisa RobinsonClincal Trials Research Unit, University of Sheffield, Sheffield, UK.
Daniel BeeverClincal Trials Research Unit, University of Sheffield, Sheffield, UK.
Alex ScottClincal Trials Research Unit, University of Sheffield, Sheffield, UK.ORCID 0000-0001-7426-7099
Sam KeatingClincal Trials Research Unit, University of Sheffield, Sheffield, UK.
Marlene HutchingsSheffield Adult Cystic Fibrosis Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield, Sheffield, UK.
Judy BradleyWellcome-Wolfson Institute For Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Julia NightingaleWessex Adult Cystic Fibrosis Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Mark I AllenbyWessex Adult Cystic Fibrosis Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Jane DewarWolfson Cystic Fibrosis Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Pauline WhelanHealth eResearch Centre - Division of Imaging, Informatics and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
John AinsworthHealth eResearch Centre - Division of Imaging, Informatics and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Stephen J WaltersSchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-9000-8126
Martin J WildmanSchool of Health and Related Research, University of Sheffield, Sheffield, UK.
Alicia O'CathainSchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0003-4033-506X

Funding

Department of Health RP-PG-1212-20015
6 · The paper itself

Abstract

objectivesTo undertake a process evaluation of an adherence support intervention for people with cystic fibrosis (PWCF), to assess its feasibility and acceptability.

settingTwo UK cystic fibrosis (CF) units.

participantsFourteen adult PWCF; three professionals delivering adherence support ('interventionists'); five multi-disciplinary CF team members.

interventionsNebuliser with data recording and transfer capability, linked to a software platform, and strategies to support adherence to nebulised treatments facilitated by interventionists over 5 months (± 1 month). PRIMARY AND SECONDARY MEASURES: Feasibility and acceptability of the intervention, assessed through semistructured interviews, questionnaires, fidelity assessments and click analytics.

resultsInterventionists were complimentary about the intervention and training. Key barriers to intervention feasibility and acceptability were identified. Interventionists had difficulty finding clinic space and time in normal working hours to conduct review visits. As a result, fewer than expected intervention visits were conducted and interviews indicated this may explain low adherence in some intervention arm participants. Adherence levels appeared to be >100% for some patients, due to inaccurate prescription data, particularly in patients with complex treatment regimens. Flatlines in adherence data at the start of the study were linked to device connectivity problems. Content and delivery quality fidelity were 100% and 60%-92%, respectively, indicating that interventionists needed to focus more on intervention 'active ingredients' during sessions.

conclusionsThe process evaluation led to 14 key changes to intervention procedures to overcome barriers to intervention success. With the identified changes, it is feasible and acceptable to support medication adherence with this intervention. TRIAL REGISTRATION NUMBER: ISRCTN13076797; Results.

Indexed as

Cystic FibrosisAdultFeasibility StudiesHumansMedication AdherenceNebulizers and VaporizersSurveys and Questionnairesclinical trialscystic fibrosishealth informaticsquality in healthcaresocial medicinestatistics & research methods

Identifiers

PMID33109661
PMCPMC7592300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.